Glyxambi® (empagliflozin and linagliptin tablets)
for Diabetes Type 2

Glyxambi (empagliflozin and linagliptin) is an oral medication used to improve blood sugar control in adults with type 2 diabetes alongside diet and exercise. Empagliflozin helps the kidneys remove glucose from the bloodstream, while linagliptin regulates insulin production after eating. Glyxambi also reduces the risk of death from heart attack, stroke, or heart failure in adults with type 2 diabetes and heart disease.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Diabetes Type 2